Some biotechs raise enough cash to take them through approval... This company has admitted that they will definitely have to have a secondary..the question is, what will be the price when that time comes
I would not drop a dime in this until the secondary is completed
Sentiment: Strong Sell
for a phase 2 drug... Chicanary
that's somebody with enough cash to wipe out stop limits
were they cashing in on ipo knowing it wasn't worth that much ?